Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3030
-0.0023 (-0.75%)
At close: May 16, 2025, 4:00 PM
0.3143
+0.0113 (3.73%)
After-hours: May 16, 2025, 7:55 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $21.55 million as of May 16, 2025. Its market cap has decreased by -90.01% in one year.
Market Cap
21.55M
Enterprise Value
-7.02M
1-Year Change
-90.01%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $21.55M, a decrease of -92.85%. That is a compound annual growth rate of -27.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 21.70M | -67.27% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.96B |
| Johnson & Johnson | 360.91B |
| AbbVie | 321.40B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 252.19B |
| Abbott Laboratories | 231.95B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |